Differding Consulting, 12, Rue de Moutfort, L-5310, Contern, Luxembourg.
Chembiochem. 2023 Nov 2;24(21):e202300302. doi: 10.1002/cbic.202300302. Epub 2023 Sep 29.
A comprehensive analysis of 2165 projects funded by India's Department of Biotechnology since 2005 through private-public partnerships, and as of 2012 through the 'Biotechnology Industry Research Assistance Council (BIRAC)' until BIRAC's tenth anniversary at the end of March 2022 reveals details of the science and technology underpinning past and current biotechnology research and development projects in the country. They are led by human healthcare projects (74.9 % overall), of which medical technology (58.7 %) and therapeutics (24.5 %) are the main drivers, ahead of vaccines (4.3 %), regenerative medicine (3.9 %), public health (3.5 %) and others (5.1 %). Agricultural projects (15.2 % overall) have mainly been driven by plant breeding and cloning (24.6 %), animal biotechnology (20.4 %), agri-informatics (13.4 %), aquaculture (6.1 %), and (bio)fertilizers (4.3 %). The key components of industrial biotechnology (9.9 % overall) have been fine chemicals (44.7 %), environmental projects (23.3 %), clean energy (18.1 %) and industrial enzymes (12.1 %). Analysis of the projects funded pre- versus post-2017, compared to the distribution of equity funding as of early 2022 identifies trends in terms of growth areas and locations of industrial biotechnology projects and activities in India.
对印度生物技术部自 2005 年以来通过公私伙伴关系资助的 2165 个项目以及截至 2012 年通过“生物技术产业研究援助理事会（BIRAC）”的项目进行全面分析，直到 2022 年 3 月底 BIRAC 成立十周年，揭示了过去和当前生物技术研发项目的科学和技术细节在该国。它们由人类医疗保健项目主导（总体占 74.9%），其中医疗技术（58.7%）和疗法（24.5%）是主要驱动力，其次是疫苗（4.3%）、再生医学（3.9%）、公共卫生（3.5%）和其他（5.1%）。农业项目（总体占 15.2%）主要由植物育种和克隆（24.6%）、动物生物技术（20.4%）、农业信息学（13.4%）、水产养殖（6.1%）和（生物）肥料（4.3%）推动。工业生物技术的关键组成部分（总体占 9.9%）一直是精细化学品（44.7%）、环境项目（23.3%）、清洁能源（18.1%）和工业酶（12.1%）。对 2017 年前后资助的项目与截至 2022 年初股权融资分布进行分析，确定了印度工业生物技术项目和活动的增长领域和地点的趋势。
